Source: BioPortfolio

GenePOC: GenePOC Inc Product Pipeline Analysis 2018 Update Report Updated 06122018 Prices from USD $750

SummaryGenePOC Inc GenePOC a subsidiary of Debiopharm Group is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers onthespot diagnostic devices for achieving optimal patient management. It offer...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Patrice Allibert's photo - CEO of GenePOC

CEO

Patrice Allibert

CEO Approval Rating

80/100

Read more